- Home
- Products
- Customized ADCs
- MSLN
- Anti-MSLN-disulfide linker-DM4 ADC
Anti-MSLN-disulfide linker-DM4 ADC (CAT#: ADC-W-426)
This ADC product is comprised of an anti-MSLN monoclonal antibody conjugated via a disulfide linker to a DM4. The DM4 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, DM4 binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Name
- MSLN
- Alternative Names
- MSLN; mesothelin; MPF; SMRP; CAK1 antigen; megakaryocyte potentiating factor; soluble MPF mesothelin related protein; pre-pro-megakaryocyte-potentiating factor;
- Target Entrez Gene ID
- 10232
- Target UniProt ID
- Q13421
- Overview
- This gene encodes a precursor protein that is cleaved into two products, megakaryocyte potentiating factor and mesothelin. Megakaryocyte potentiation factor functions as a cytokine that can stimulate colony formation in bone marrow megakaryocytes. Mesothelian is a glycosylphosphatidylinositol-anchored cell-surface protein that may function as a cell adhesion protein. This protein is overexpressed in epithelial mesotheliomas, ovarian cancers and in specific squamous cell carcinomas. Alternative splicing results in multiple transcript variants.
- Overview
- Human Anti-MSLN Antibody
- Species Reactivity
- Human
- Name
- Cleavable, disulfide linker
- Name
- DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine)
- Description
- Derived from Maytansinoid,a group of cytotoxins structurally similar to rifamycin, geldanamycin, and ansatrienin. The eponymous natural cytotoxic agent maytansine is a 19-member lactam (ansa
macrolide) structure originally isolated from the Ethiopian shrub Maytenus ovatus. Maytansinoids can bind to tubulin at or near the vinblastine-binding site, which interfere the formation of microtubules and depolymerize already formed microtubules, inducing mitotic arrest in the intoxicated cells.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-RhD (Atorolimumab)-SMCC-DM1 ADC (CAT#: ADC-W-1718)
- Anti-RhD (Atorolimumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1722)
- Anti-MUC16 (Sofituzumab)-SMCC-DM1 ADC (CAT#: ADC-W-2565)
- Anti-ANGPT2 MC-MMAF ADC (CAT#: ADC-W-664)
- Anti-KDR (Ramucirumab)-SPDB-DM4 ADC (CAT#: ADC-W-1515)
- Anti-HBV surface antigen (Libivirumab)-MC-MMAF ADC (CAT#: ADC-W-1972)
- Anti-GPNMB-VC-MMAE ADC (CAT#: ADC-W-462)
- Anti-APP (Ponezumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-713)
- Anti-CD22-Mc-MMAF ADC-9 (CAT#: ADC-W-217)
- Anti-EPCAM (Adecatumumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-1075)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-426. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Payload
| CAT# | Product Name | Linker | Payload |
| ADC-W-1595 | Anti-MSLN (Amatuximab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-454 | Anti-MSLN-Mc-MMAF ADC-2 | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-1597 | Anti-MSLN (Amatuximab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-455 | Anti-MSLN-Mc-VC-PABC-MMAE ADC-2 | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE (Monomethyl auristatin E) |
| ADC-W-1596 | Anti-MSLN (Amatuximab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| CAT# | Product Name | Linker | Payload |
| ADC-W-324 | Anti-CD19-SPDB-DM4 ADC-3 | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-320 | Anti-SDC1-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-2595 | Anti-ERBB2 (Trastuzumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-422 | Anti-ITGAV-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-2599 | Anti-GPNMB (Glembatumumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.